Nothing Special   »   [go: up one dir, main page]

CERN Accélérateur de science

CERN Document Server 3 notices trouvées  La recherche a duré 0.56 secondes. 
1.
“Particle therapy - future for the Baltic states?” – synthesis of the expert workshop report / Paļskis, Kristaps (Riga Tech. U. ; CERN) ; Korobeinikova, Erika ; Bogorada-Saukuma, Dace ; Camarda, Anna Maria (CNAO, Milan) ; Taylor, Rebecca (CERN ; Imperial Coll., London) ; Benedetto, Elena ; Mamis, Edgars (CERN ; Latvia U.) ; Radziņa, Maija ; Ērglis, Andrejs (Latvia U.) ; Adliene, Diana et al.
Background Baltic States remains one of the few regions in the Europe without a dedicated particle therapy center. An initiative since 2021 has been started by CERN Baltic Group on a novel particle therapy center development in the region in partnership with CERN NIMMS collaboration. [...]
2024 - 8 p. - Published in : Health Technol. 14 (2024) 965-972 Fulltext: PDF;
2.
Target Development towards First Production of High-Molar- Activity $^{44g}$Sc and $^{47}$Sc by Mass Separation at CERN-MEDICIS / Mamis, Edgars (CERN ; Latvia U.) ; Duchemin, Charlotte (CERN) ; Berlin, Valentina (CERN) ; Bernerd, Cyril (CERN) ; Bovigny, Mathieu (CERN) ; Chevallay, Eric (CERN) ; Crepieux, Bernard (CERN) ; Gadelshin, Vadim Maratovich (Mainz U., Inst. Phys.) ; Heinke, Reinhard (CERN) ; Hernandez, Ronaldo Mendez (CERN ; Havana, ISCTN) et al.
The radionuclides 43Sc,  44g/mSc, and 47Sc can be produced cost-effectively in sufficient yield for medical research and applications by irradiating  natTi and  natV target materials with protons. Maximizing the production yield of the therapeutic 47Sc in the highest cross section energy range of 24–70 MeV results in the co-production of long-lived, high-γ-ray-energy 46Sc and 48Sc contaminants if one does not use enriched target materials. [...]
2024 - 28 p. - Published in : Pharmaceuticals 17 (2024) 390 Fulltext: PDF;
3.
Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go? / Radzina, Maija (Latvia U. ; CERN) ; Saule, Laura (Latvia U.) ; Mamis, Edgars (Latvia U. ; CERN) ; Koester, Ulli (Laue-Langevin Inst.) ; Cocolios, Thomas Elias (Leuven U.) ; Pajuste, Elina (Latvia U.) ; Kalnina, Marika (Unlisted) ; Palskis, Kristaps (CERN ; Riga Tech. U.) ; Sawitzki, Zoe (Leuven U.) ; Talip, Zeynep (PSI, Villigen) et al.
Background In order to support the ongoing research across Europe to facilitate access to novel radionuclides, the PRISMAP consortium (European medical radionuclides programme) was established to offer the broadest catalog of non-conventional radionuclides for medical and translational research. The aim of this article is to introduce readers with current status of novel radionuclides in Europe. Main body A consortium questionnaire was disseminated through the PRISMAP consortium and user community, professional associations and preclinical/clinical end users in Europe and the current status of clinical end-users in nuclear medicine were identified. [...]
2023 - 16 p. - Published in : EJNMMI Radiopharm. Chem. 8 (2023) 27 Fulltext: PDF;

Voir aussi: noms d'auteurs similaires
3 Mamis, E
Vous désirez être averti des nouveaux résultats pour cette recherche?
Abonnez-vous à une alerte email personnalisée ou inscrivez-vous via le flux RSS.
Vous n'avez pas trouvé ce que vous avez cherché? Essayez votre requête sur d'autres serveurs:
Mamis, Edgars dans Amazon
Mamis, Edgars dans CERN EDMS
Mamis, Edgars dans CERN Intranet
Mamis, Edgars dans CiteSeer
Mamis, Edgars dans Google Books
Mamis, Edgars dans Google Scholar
Mamis, Edgars dans Google Web
Mamis, Edgars dans IEC
Mamis, Edgars dans IHS
Mamis, Edgars dans INSPIRE
Mamis, Edgars dans ISO
Mamis, Edgars dans KISS Books/Journals
Mamis, Edgars dans KISS Preprints
Mamis, Edgars dans NEBIS
Mamis, Edgars dans SLAC Library Catalog
Mamis, Edgars dans Scirus